Health
Phase 1 trial results of gorilla adenovirus vaccine for COVID-19 – News-Medical.Net
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained…
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help speed up vaccine development.
Low Seroprevalence for Simian Adenoviruses
Simian adenoviruses are isolated from non-human primates like the chimpanzee and gorilla and do not infect humans. Their prevalence is, therefore, low or non-existent among humans. They have been used to…
-
Noosa News14 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News16 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General13 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
General20 hours agoOne person dead after house fire in Melbourne’s south-east